Phase 1 safety lead-in and randomized open-label perioperative study of vorasidenib combined with pembrolizumab in recurrent or progressive enhancing IDH1-mutant astrocytomas: Safety lead-in results Meeting Abstract
| Authors: | Wen, P.; Peters, K.; de la Fuente, M.; Mellinghoff, I.; Arrillaga-Romany, I.; Kumthekar, P.; Clarke, J.; Puduvalli, V.; de Groot, J.; Zhang, X. M.; Chisamore, M.; Abshire, M.; Mahboub, P.; Hassan, I.; Knipstein, J.; Cloughesy, T. |
| Abstract Title: | Phase 1 safety lead-in and randomized open-label perioperative study of vorasidenib combined with pembrolizumab in recurrent or progressive enhancing IDH1-mutant astrocytomas: Safety lead-in results |
| Meeting Title: | 28th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 25 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Nov 15-19 |
| Meeting Location: | Vancouver, Canada |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | v64 |
| Language: | English |
| ACCESSION: | WOS:001115245400255 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noad179.0254 |
| Notes: | Meeting Abstract: CTIM-14 -- Source: Wos |
